الابحاث

South Egypt Cancer Institute

Assiut University

Department of Medical Oncology
# Title Research Member Research Year
111 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

 		Prof. Ashraf Zeidan Abdalla Ahmed 2020
112 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

 		Dr. Hanaan Ahmed Mohammed Ahmed 2020
113 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
 		Dr. Abeer Elsayed Ali Ibrahim 2020
114 Predictive and Prognostic Factors for the Outcome of the Patients Receiving Pegylated Liposomal Doxorubicin for Advanced Breast Cancer Dr. Abeer Elsayed Ali Ibrahim 2020
115 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
 		Dr. Amen Hamdy Zaki Ali 2019
116 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
 		Prof. Ashraf Zeidan Abdalla Ahmed 2019
117 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
 		Dr. Mayada Fawzy Sedik Farghaly 2019
118 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
 		Dr. Hanaan Ahmed Mohammed Ahmed 2019
119 The Prognostic Implication of CD49d Expression by Flow Cytometry and Trisomy 12 Detection by Fluorescent in situ Hybridization in Chronic Lymphocytic Leukemia Dr. Mayada Fawzy Sedik Farghaly 2019
120 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
 		Dr. Amen Hamdy Zaki Ali 2019